Skip to main content

Table 4 Amplification efficiency of tested miRNAs at optimized annealing temperature (n = 3)

From: Screening of miRNAs in plasma as a diagnostic biomarker for cardiac disease based on optimization of extraction and qRT-PCR condition assay through amplification efficiency

miRNAs

Annealing temperature (°C)

Median Efficiency (%)

Range

95% CI

Cel-miRNA-39-1

60

91.2

99.0–89.8

81.1–105.4

miRNA-16

65

97.6

107.6–93.0

80.9–117.9

miRNA-21

65

98.1

106.3–96.4

87.1–113.4

miRNA-132

60

95. 2

95.8–85.2

77.3–106.9

miRNA-155

65

108.7

112.7–86.5

67.6–137.7

miRNA-499

65

94.9

94.6–95.4

93.9–96.0